Danaher Corporation logo

Danaher Corporation DHR

$ 233.03 0.95%

Annual report 2023
added 02-21-2024

report update icon

Country

usaUSA

IPO year

-

Industry

Diagnostics research

Stock Exchange

NYSESPB

CEO

Mr. Thomas Joyce

Employees in the company

60 000

Shares

736 M

Market Cap[1]

$ 172 B

EBITDA (LTM)

$ 8.21 B

P/E (LTM)

28.61

P/S (LTM)

6.02

EPS (LTM)

8.63

Danaher Corporation is an American diversified conglomerate that manufactures and sells a wide range of industrial and scientific products. Founded in 1984, the company is now one of the largest corporations in the world. Product portfolio includes tools for medical and scientific research, industrial automation and quality control systems, water analysis equipment, and many other goods. The company offers its products in more than 125 countries around the world.

One of Danaher Corporation's key principles is continuous development and innovation. The company invests significant resources in scientific research and the development of new technologies, which has helped it to achieve leading positions in many industries. Also known for its management strategy, called the Danaher Business System (DBS). This system is based on Lean Manufacturing and Six Sigma principles and enables the company to effectively manage its processes and achieve high results.

Overall, it's a successful and innovative company that holds leading positions in many industries. Thanks to its management strategy and constant investments in scientific research, the company continues to grow and attract new customers from all over the world.

Other stocks of industry "Diagnostics research"

Issuer Price % 24h Market Cap Exchange Country
Genetron Holdings Limited Genetron Holdings Limited
GTH
$ 4.03 0.12 % $ 80.1 M Nasdaq Global Market chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
$ 3.75 1.08 % $ 308 M Nasdaq Global Select Market usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
$ 2.99 - $ 399 M NYSE chinaChina
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
$ 21.99 - $ 562 M Nasdaq Global Select Market britainBritain
Chembio Diagnostics Chembio Diagnostics
CEMI
$ 0.46 0.22 % $ 16.8 M Nasdaq Capital Market usaUSA
Bioventus Bioventus
BVS
$ 11.31 -2.42 % $ 709 M Nasdaq Global Select Market usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 416.92 0.14 % $ 34.6 B Nasdaq Global Select Market,SPB usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
$ 33.97 - $ 1.49 B Nasdaq Global Select Market usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
$ 0.48 -20.0 % $ 1.06 M Nasdaq Capital Market usaUSA
Quotient Limited Quotient Limited
QTNT
$ 0.32 -11.32 % $ 1.1 M Nasdaq Global Select Market schweizSchweiz
Personalis Personalis
PSNL
$ 2.17 -14.57 % $ 102 M Nasdaq Global Select Market usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
$ 165.21 - $ 10.7 B Nasdaq Global Select Market usaUSA
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
$ 511.28 0.42 % $ 197 B NYSE,SPB usaUSA
Heska Corporation Heska Corporation
HSKA
$ 119.99 - $ 1.31 B Nasdaq Capital Market,SPB usaUSA
Agilent Technologies Agilent Technologies
A
$ 127.92 1.77 % $ 38.9 B NYSE,SPB usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
$ 41.0 -0.77 % $ 2.38 B Nasdaq Global Select Market,SPB usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 0.78 -1.27 % $ 22.1 M Nasdaq Capital Market israelIsrael
Motus GI Holdings Motus GI Holdings
MOTS
$ 0.17 -34.28 % $ 263 K Nasdaq Global Select Market israelIsrael
Biocept Biocept
BIOC
$ 0.43 -13.05 % $ 7.29 M Nasdaq Capital Market usaUSA
T2 Biosystems T2 Biosystems
TTOO
$ 0.47 -3.11 % $ 1.23 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.